Home
Most Popular ETFsCrypto ETFsPercent GainersPercent LosersFollowed

News

Advance/Decline Line: The Market’s Truth Serum in Disguisetalkmarkets.com
In an era of ETF dominance and passive investing, understanding broad market participation becomes even more critical for active managers seeking genuine alpha rather than expensive beta.
Via Talk Markets · July 12, 2025
This Dividend ETF Is Near Its Highest Level Ever -- Is It Too Late to Invest in It?fool.com
Via The Motley Fool · July 12, 2025
Signal Advisors Loads Up on 29,843 AAPL Sharesfool.com
Via The Motley Fool · July 12, 2025
Rocket Lab And Kratos Are Setting Defense ETFs On Firebenzinga.com
Rocket Lab and Kratos are driving a surge in defense ETFs like SHLD and XAR, as Pentagon policies boost demand for drones, AI, and space tech.
Via Benzinga · July 12, 2025
Elizabeth Warren Once Warned that Dogecoin Is for 'Speculators And Fly-By-Night Investors' — Today, Asset Managers Are Racing To Bring DOGE ETFs To Wall Streetbenzinga.com
Sen. Elizabeth Warren (D-Mass.) has been one of the most vocal cryptocurrency critics in politics, using her position to press for stricter regulation of the industry.
Via Benzinga · July 12, 2025
Where Will ARK 21Shares Bitcoin ETF Be in 5 Years?fool.com
Get the facts on fees, features, and expectations for the next few years.
Via The Motley Fool · July 12, 2025
The Bitcoin ETF craze has triggered the demand for cloud mining and FIND MINING has become the first choice for global investors
Against the backdrop of Bitcoin halving and large-scale approval of ETFs, FIND MINING has overturned the traditional mining landscape and led a new trend in global cloud mining with its safe, convenient and efficient profit model.
Via Binary News Network · July 12, 2025
2 High-Yield Dividend ETFs to Buy With $100 and Hold Foreverfool.com
Via The Motley Fool · July 12, 2025
Motley Fool CEO Tom Gardner: S&P 500 (VOO) at 25× Earnings Is Stretching Valuationsfool.com
Via The Motley Fool · July 12, 2025
Could a $2,000 Investment in Ethereum Turn Into $10,000 by 2030?fool.com
Via The Motley Fool · July 12, 2025
XRP: Buy the Dip?fool.com
Via The Motley Fool · July 12, 2025
The Smartest Vanguard ETF to Buy With $1,000 Right Nowfool.com
Even if it's not easy to see or feel, a sea-change is brewing for the stock market.
Via The Motley Fool · July 12, 2025
MicroStrategy vs. Bitcoin: What's the Better Crypto Investment?fool.com
Via The Motley Fool · July 12, 2025
Tandem Diabetes, Solventum, LeMaitre, UFP Technologies, and Artivion Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned negative after the White House announced plans to impose a 35% tariff on Canadian imports, sparking renewed fears of a trade war. This news prompted a sell-off across major U.S. indexes, including the S&P 500 and the Dow Jones Industrial Average, as investors grew concerned about the potential economic impact of escalating protectionist policies. The healthcare sector is especially vulnerable to such tensions due to its deeply integrated supply chains with Canada for pharmaceuticals and medical devices, meaning increased costs and potential disruptions. 
Via StockStory · July 11, 2025
Why Owens & Minor (OMI) Shares Are Sliding Today
Shares of medical supply and logistics company Owens & Minor (NYSE:OMI) fell 3% in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned negative after the White House announced plans to impose a 35% tariff on Canadian imports, sparking renewed fears of a trade war. This news prompted a sell-off across major U.S. indexes, including the S&P 500 and the Dow Jones Industrial Average, as investors grew concerned about the potential economic impact of escalating protectionist policies. The healthcare sector is especially vulnerable to such tensions due to its deeply integrated supply chains with Canada for pharmaceuticals and medical devices, meaning increased costs and potential disruptions. 
Via StockStory · July 11, 2025
Guardant Health, Gilead Sciences, Inspire Medical Systems, Enovis, and AMN Healthcare Services Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. 
Via StockStory · July 11, 2025
U.S. Physical Therapy, Evolent Health, Charles River Laboratories, Moderna, and Intuitive Surgical Shares Are Falling, What You Need To Know
A number of stocks fell in the morning session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. 
Via StockStory · July 11, 2025
Lantheus, ICU Medical, Haemonetics, CONMED, and Astrana Health Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. 
Via StockStory · July 11, 2025
NeoGenomics, RadNet, Pediatrix Medical Group, Penumbra, and Neogen Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. 
Via StockStory · July 11, 2025
Why Bristol-Myers Squibb (BMY) Shares Are Sliding Today
Shares of biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) fell 3.5% in the afternoon session after a cautious analyst note from UBS highlighting significant upcoming expenses and other headwinds. Ahead of its second-quarter earnings report, UBS reiterated its "Neutral" rating on the stock. The firm's note pointed to several challenges, including an expected $1.5 billion expense for in-process research and development (IPR&D) related to a collaboration with BioNTech. This charge is anticipated to reduce the company's earnings per share (EPS) by approximately $0.60. The report also touched on broader investor concerns, such as the impact of Medicare's Part D redesign on several of the company's high-priced drugs and the looming patent expirations for key products. These factors contribute to a more cautious outlook on the pharmaceutical giant's near-term profitability and growth prospects. 
Via StockStory · July 11, 2025
Masimo, STAAR Surgical, Teleflex, Omnicell, and Integra LifeSciences Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. 
Via StockStory · July 11, 2025
Acadia Healthcare, 10x Genomics, Amphastar Pharmaceuticals, Myriad Genetics, and QuidelOrtho Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. 
Via StockStory · July 11, 2025
Tradr's New ETFs Are A Rebellion Against Boring Portfoliosbenzinga.com
Tradr ETFs has launched five new leveraged single-stock ETFs, offering 2x daily returns on high-risk, high-reward stocks like CoreWeave and AST SpaceMobile.
Via Benzinga · July 11, 2025
Standard Chartered Predicts Bitcoin Will Hit $135,000 by the End of Septemberfool.com
Via The Motley Fool · July 11, 2025
Vanguard's New ETFs Are Built For What Keeps Investors Up At Nightbenzinga.com
Vanguard debuts three bond ETFs designed to help investors navigate volatility, inflation risk, and rate uncertainty with a range of defensive fixed-income strategies.
Via Benzinga · July 11, 2025